Abstract
Sampling the mucosal tissues and analyses of immune responses are integral to vaccine-development strategies against human immunodeficiency virus (HIV), which is transmitted predominantly across the oro-genital mucosa. While immune assay development and standardization attempts employ mouse models, immunogenicity and protective efficacy that can be extrapolated to humans are realized only from experiments in nonhuman primates. Here, we describe commonly used practices for immunizations in rhesus macaques (Macaca mulatta) along with procedures for obtaining important mucosal tissues samples from macaques and mice. We also describe detailed protocols for two important assays applicable in mouse as well as primate experiments for determining antigen-specific T cells responses induced after vaccination.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gamble LJ, Matthews QL (2010) Current progress in the development of a prophylactic vaccine for HIV-1. Drug Des Devel Ther 5:9–26
Girard MP, Osmanov SK, Kieny MP (2006) A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 19:4062–4081
Kim JH, Rerks-Ngarm S, Excler JL et al (2010) HIV vaccines: lessons learned and the way forward. Curr Opin HIV AIDS 5:428–3
Esparza J, Osmanov S (2003) HIV vaccines: a global perspective. Curr Mol Med 3:183–193
Hu SL (2005) Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 2:193–201
Duerr A (2010) Update on mucosal HIV vaccine vectors. Curr Opin HIV AIDS 5:397–403
Nehete PN, Singh S, Sastry KJ (2013) Lessons on non-progression of HIV disease from monkeys. Front Immunol 4:64
Nehete PN, Nehete BP, Hill L et al (2008) Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail. Virology 370:130–141
Sastry KJ, Nehete PN, Venkatnarayanan S et al (1992) Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120. Virology 188:502–509
Weaver EA, Nehete PN, Nehete BP et al (2009) Protection against mucosal SHIV challenge by peptide and helper-dependent adenovirus vaccines. Viruses 1:920
Murphy KL, Baxter MG, Flecknell PA (2012) Anesthesia and analgesia in nonhuman primates. In: Abee CR, Mansfield K, Tardif SD et al (eds) Nonhuman primates in biomedical research: biology and management. Academic, San Diego, CA, pp 403–436
Popilskis SJ, Lee DR, Elmore DB (2011) Anesthesia and analgesia in nonhuman primates. In: Fish R, Danneman PJ, Brown M, Karas A (eds) Anesthesia and analgesia in laboratory animals. Academic, San Diego, CA, pp 335–363
Bellanti JA, Zeligs BJ, Mendez de Inocencio J et al (2001) Alternative routes of immunization for prevention of infectious diseases: a new paradigm for the 21st century. Allergy Asthma Proc 22:173–176
Scherliess R (2011) Delivery of antigens used for vaccination: recent advances and challenges. Ther Deliv 2:1351–1368
Meeusen EN (2011) Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 29:8506–8511
Demberg T, Robert-Guroff M (2009) Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int Rev Immunol 28:20–48
Pachuk CJ, McCallus DE, Weiner DB, Satishchandran C (2000) DNA vaccines—challenges in delivery. Curr Opin Mol Ther 2:188–189
Dunn TB (1954) Normal and pathological anatomy of the reticular tissue in laboratory mice. J Natl Cancer Inst 14:1281–1434
Covelli V (2013) Guide to the necropsy of the mouse. http://eulep.pdn.cam.ac.uk/Necropsy_of_the_Mouse. Accessed 28 July 2013
Reeves JP, Reeves PA (2001) Removal of lymphoid organs. Curr Protoc Immunol 1:1.9.1–1.9.3
Fuss IJ, Kanof ME, Smith PD, Zola H (2009) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol 85:7.1.1–7.1.8
Ulmer AJ, Scholz W, Ernst M et al (1984) Isolation and subfractionation of human peripheral blood mononuclear cells (PBMC) by density gradient centrifugation on Percoll. Immunobiology 166:238–250
Schluns KS, Nowak EC, Cabrera-Hernandez A et al (2004) Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression. Proc Natl Acad Sci U S A 101:5616–5621
Sheridan BS, Lefrançois L (2012) Isolation of mouse lymphocytes from small intestine tissues. Curr Protoc Immunol 99:3.19.1–3.19.11
Seifter S, Gallop PM, Klein L et al (1959) Studies on collagen, part II. Properties of purified collagenase and its inhibition. J Biol Chem 234:285
Koup RA, Douek DC (2011) Vaccine design for CD8 T lymphocyte responses. Cold Spring Harb Perspect Med 1(1):a007252. doi:10.1101/cshperspect.a007252
Appay V, Douek DC, Price DA (2008) CD8+ T cell efficacy in vaccination and disease. Nat Med 14:623–628
Swain SL, McKinstry KK, Strutt TM (2012) Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol 12:136–148
Perrin H, Canderan G, Sékaly RP, Trautmann L (2010) New approaches to design HIV-1T-cell vaccines. Curr Opin HIV AIDS 5:368–376
Schmittel A, Keilholz U, Thiel E, Scheibenbogen C (2000) Quantification of tumor-specific T lymphocytes with the ELISPOT assay. J Immunother 23:289–295
De Rosa SC (2012) Vaccine applications of flow cytometry. Methods 57:383–391
Lehmann PV, Zhang W (2012) Unique strengths of ELISPOT for T cell diagnostics. Methods Mol Biol 792:3–23
Kalyuzhny AE (2005) Chemistry and biology of the ELISPOT assay. In: Kalyuzhny AE (ed) Handbook of ELISPOT: methods and protocols. Humana Press, Totowa, pp 15–31
Lehman PV (2005) Image analysis and data management of ELISPOT assay results. In: Kalyuzhny AE (ed) Handbook of ELISPOT: methods and protocols. Humana Press, Totowa, pp 117–132
Weaver EA, Nehete PN, Nehete BP et al (2013) Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PLoS One 8(7):e67574. doi:10.1371/journal.pone.0067574
Smith SG, Joosten SA, Verscheure V et al (2009) Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 4(11):e7972. doi:10.1371/journal.pone.0007972
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Singh, S. et al. (2014). Procedures for Mucosal Immunization and Analyses of Cellular Immune Response to Candidate HIV Vaccines in Murine and Nonhuman Primate Models. In: De, R., Tomar, N. (eds) Immunoinformatics. Methods in Molecular Biology, vol 1184. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1115-8_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1115-8_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1114-1
Online ISBN: 978-1-4939-1115-8
eBook Packages: Springer Protocols